CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience

Riccardo Bomben; Antonella Zucchetto; Roberta Laureana; Annalisa Chiarenza; Jacopo Olivieri; Erika Tissino; Francesca M Rossi; Filippo Vit; Tamara Bittolo; Robel Papotti; Federico Pozzo; Annalisa Gaglio; Massimo Degan; Jerry Polesel; Roberto Marasca; Andrea Visentin; Riccardo Moia; Idanna Innocenti; Candida Vitale; Roberta Murru; Marzia Varettoni; Agostino Tafuri; Francesco Zaja; Massimiliano Postorino; Enrica A Martino; Adalgisa Condoluci; Davide Rossi; Antonio Cuneo; Francesco Di Raimondo; Paolo Sportoletti; Ilaria Del Giudice; Robin Foà; Francesca R Mauro; Marta Coscia; Luca Laurenti; Gianluca Gaidano; Livio Trentin; Maria I Del Principe; Massimo Gentile; Valter Gattei

doi:10.1002/hem3.128

CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience

Hemasphere. 2024 Jul 15;8(7):e128. doi: 10.1002/hem3.128. eCollection 2024 Jul.

Authors

Riccardo Bomben¹, Antonella Zucchetto¹, Roberta Laureana², Annalisa Chiarenza³, Jacopo Olivieri⁴, Erika Tissino¹, Francesca M Rossi¹, Filippo Vit¹, Tamara Bittolo¹, Robel Papotti¹, Federico Pozzo¹, Annalisa Gaglio¹, Massimo Degan¹, Jerry Polesel⁵, Roberto Marasca^{6

7}, Andrea Visentin⁸, Riccardo Moia⁹, Idanna Innocenti¹⁰, Candida Vitale¹¹, Roberta Murru¹², Marzia Varettoni¹³, Agostino Tafuri¹⁴, Francesco Zaja¹⁵, Massimiliano Postorino², Enrica A Martino¹⁶, Adalgisa Condoluci¹⁷, Davide Rossi¹⁷, Antonio Cuneo¹⁸, Francesco Di Raimondo³, Paolo Sportoletti¹⁹, Ilaria Del Giudice²⁰, Robin Foà²⁰, Francesca R Mauro²⁰, Marta Coscia¹¹, Luca Laurenti¹⁰, Gianluca Gaidano⁹, Livio Trentin⁸, Maria I Del Principe², Massimo Gentile^{16

21}, Valter Gattei¹

Affiliations

¹ Clinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy.
² Division of Haematology University of Tor Vergata Rome Italy.
³ Division of Hematology, Policlinico, Department of Surgery and Medical Specialties University of Catania Catania Italy.
⁴ Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi" DISM Azienda Ospedaliera Universitaria S. Maria Misericordia Udine Italy.
⁵ Unit of Cancer Epidemiology Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy.
⁶ Hematology Unit, Department of Oncology and Hematology Azienda-Ospedaliero Universitaria (AOU) of Modena, Policlinico Modena Italy.
⁷ Department of Medical and Surgical Sciences University of Modena e Reggio Emilia Emilia-Romagna Italy.
⁸ Hematology unit, Department of Medicine University of Padova Padova Italy.
⁹ Division of Hematology, Department of Translational Medicine Università del Piemonte Orientale Novara Italy.
¹⁰ Fondazione Universitaria Policlinico A Gemelli di Roma Roma Italy.
¹¹ A.O.U. Città della Salute e della Scienza di Torino Torino Italy.
¹² Hematology and Stem Cell Transplantation Unit, Ospedale A. Businco, ARNAS G. Brotzu Cagliari Italy.
¹³ Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy.
¹⁴ Department of Clinical and Molecular Medicine and Hematology, Sant'Andrea - University Hospital - Sapienza University of Rome Rome Italy.
¹⁵ Department of Medical, Surgical and Health Sciences University of Trieste Trieste Italy.
¹⁶ Hematology Unit Azienda Ospedaliera Annunziata Cosenza Italy.
¹⁷ Oncology Institute of Southern Switzerland and Institute of Oncology Research Bellinzona Switzerland.
¹⁸ Hematology Section, Department of Medical Sciences University of Ferrara Ferrara Italy.
¹⁹ Centro di Ricerca Emato-Oncologica (CREO), Dipartimento di Medicina e Chirurgia Università di Perugia Perugia Italy.
²⁰ Hematology, Department of Translational and Precision Medicine 'Sapienza' University Rome Italy.
²¹ Department of Pharmacy, Health and Nutritional Science University of Calabria Rende Italy.

No abstract available